Influenza Archives
Study explores parents’ reluctance to flu, COVID vaccines for children
Apr. 7, 2022—Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.
Study compares kidney injury risk for COVID, flu patients
Mar. 17, 2022—A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.
Study to explore neurologic impact of flu treatment
Feb. 24, 2022—A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu.
Grant boosts vaccine effectiveness research
Jan. 6, 2022—by Nancy Humphrey Investigators at Vanderbilt University Medical Center have received a $10.7 million research award from the Centers for Disease Control and Prevention (CDC) to continue the IVY Research Network, originally created in 2019 to look at how well flu vaccines work at preventing severe flu illness, and expanded in 2021 to enroll patients...
COVID testing recommended for flu-like symptoms
Nov. 3, 2021—Vanderbilt physicians recommend COVID testing for people who think they may have the flu because the symptoms for both infections overlap.
Neurologic complications of the flu
Oct. 4, 2021—Neurologic complications are common in children hospitalized with influenza, especially those with chronic neurologic conditions, and are associated with worse outcomes.
Influenza network sizes up COVID
Jul. 22, 2021—Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients.
Questions, answers on flu season and COVID
Sep. 24, 2020—Infectious diseases specialist Thomas Talbot, MD, MPH, chief hospital epidemiologist at Vanderbilt University Medical Center, answers questions about the rapidly approaching U.S. flu season and how it might play into the COVID-19 pandemic.
Flu shots available beginning week of Sept. 7
Aug. 18, 2020—This year’s effort by Vanderbilt University Medical Center to protect its people from influenza will be the most important in a century. With COVID-19 already prevalent, consuming precious health care resources, endangering lives, and so far, killing more than 170,000 Americans, this is not the year to shun getting a flu vaccine.
Occupational Health invites you to name this year’s flu vaccine campaign
Aug. 10, 2020—In 2011 Vanderbilt University Medical Center received worldwide attention for doubling the Guinness World Record for the number of flu shots given in an 8-hour period, making its annual flu vaccine event, Flulapalooza, a model for others to follow.
Cellular factor helps package flu genome
Mar. 23, 2020—New insights on influenza genome packaging could guide strategies for interfering with the virus’s life cycle and ability to cause infection.
Vaccine study seeks to halt flu’s most severe side effects
Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
